BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2026.
World J Gastroenterol. Jan 21, 2026; 32(3): 113187
Published online Jan 21, 2026. doi: 10.3748/wjg.v32.i3.113187
Table 4 Serum clusters of differentiation 24 and hepatocellular carcinoma markers in hepatocarcinogenesis (mean ± SD)
MarkerNC (n = 12)Model rats in hepatocarcinogenesis
Early (n = 17)Middel (n = 15)Late (n = 10)
CD24 (μg/L)3.68 ± 0.637.28 ± 3.17a10.61 ± 4.52b14.33 ± 7.14b
ALT (IU/L)14.75 ± 3.0262.19 ± 29.79b55.55 ± 26.80b46.08 ± 13.39b
AST (IU/L)15.88 ± 3.2944.46 ± 9.25c61.99 ± 18.21c47.91 ± 21.22c
CD44 (μg/L)5.32 ± 1.6612.36 ± 8.18b21.69 ± 5.38b28.6 ± 9.14b
AFP (μg/L)0.81 ± 0.161.25 ± 0.321.58 ± 0.51a1.96 ± 0.75b
Wnt3a (μg/L)0.96 ± 0.472.25 ± 2.246.28 ± 2.12b9.98 ± 5.62c
GPC-3 (μg/L)0.02 ± 0.081.01 ± 0.271.62 ± 0.42a5.83 ± 1.54b


Write to the Help Desk